2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Indications for Metabolic and Bariatric Surgery

Major updates to 1991 National Institutes of Health guidelines for bariatric surgeryMetabolic and bariatric surgery (MBS) is recommended for individuals with a body mass index (BMI) >35 kg/m2, regardless of presence, absence, or severity of co-morbidities.MBS should be considered for individuals with metabolic disease and BMI of 30-34.9 kg/m2.BMI thresholds should be adjusted in the Asian population such that a BMI >25 kg/m2 suggests clinical obesity, and individuals with BMI >27.5 kg/m2 should be offered MBS.Long-term results of MBS consistently demonstrate safety and efficacy.Appropriately selected children and adolescents should be considered for MBS.(Surg Obes Relat Dis 2022; https://doi.org/10.1016/j.soard.2022.08.013) © 2022 American Society for Metabolic and Bariatric Surgery. All rights reserved.

Topics

No keywords indexed for this article. Browse by subject →

References

148

[1]

Gastrointestinal surgery for severe obesity. Consens Statement 1991;9(1):1–20.

[2]

Ogden CL, Carroll MD, Kit BK, Flegal KL. Prevalence of childhood and adult obesity in the United States 2011–12. JAMA. 2014;311(8):806–14. 10.1001/jama.2014.732

[3]

World Health Organization (WHO) [monograph on the Internet]. Geneva: World Health Organization; 2002 [cited 2022 Mon D]. Available from: https://www.who.int/publications/i/item/9241562072.

[4]

Gossman H, Butsch WS, Jastreboff AM. Treating the chronic disease of obesity. Med Clin N Am. 2021;105(6):983–1016. 10.1016/j.mcna.2021.06.005

[5]

Adipose tissue inflammation and metabolic dysfunction in obesity

Tatsuo Kawai, Michael V. Autieri, Rosario Scalia

American Journal of Physiology-Cell Physiology 2021 10.1152/ajpcell.00379.2020

[6]

Inflammation and metabolic disorders

Gökhan S. Hotamisligil

Nature 2006 10.1038/nature05485

[7]

Grosfeld A, Andre J, Hauguel-De Mouzon S, Berra E, Poussegur J, Guerre-Millo M. Hypoxia-inducible factor 1 transactivates the human leptin gene promoter. J Biol Chem. 2002;277(45):42953–7. 10.1074/jbc.m206775200

[8]

Chang SS, Eisenberg D, Zhao L, Adams C, Leib R, Morser J, Leung L. Chemerin activation in human obesity. Obesity (Silver Spring). 2016;24(7):1522–9. 10.1002/oby.21534

[9]

Gloy VL, Briel M, Bhatt DL, Kashyap SR, Schauer PR, Mingrone G, Bucher HC, Nordmann AJ. Bariatric surgery versus non-surgical treatment of obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ. 2013;347:f5934. 10.1136/bmj.f5934

[10]

Adams TD, Davidson LE, Litwin SE, Kim J, Kolotkin RL, Nanjee MN, Gutierrez JM, Frogley SJ, Ibele AR, Brinton EA, Hopkins PN, McKinlay R, Simper SC, Hunt SC. Weight and metabolic outcomes 12 years after gastric bypass. N Engl J Med. 2017;377(12):1143–55. 10.1056/nejmoa1700459

[11]

Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years after Bariatric Surgery

Lars Sjöström, Anna-Karin Lindroos, Markku Peltonen et al.

New England Journal of Medicine 2004 10.1056/nejmoa035622

[12]

Bariatric Surgery and Long-term Cardiovascular Events

Lars Sjöström, Markku Peltonen, Peter Jacobson et al.

JAMA 2012 10.1001/jama.2011.1914

[13]

Long-term Follow-up After Bariatric Surgery

Nancy Puzziferri, Thomas B. Roshek, Helen G. Mayo et al.

JAMA 2014 10.1001/jama.2014.10706

[14]

Maciewjewski ML, Arterburn DE, Van Scoyoc L, et al. Bariatric surgery and long-term durability of weight loss. JAMA Surg. 2016;151(11):1046–55. 10.1001/jamasurg.2016.2317

[15]

Schauer PR, Mingrone G, Ikramuddin S, Wolfe B. Clinical outcomes of metabolic surgery: efficacy of glycemic control, weight loss, and remission of diabetes. Diabetes Care. 2016;39(6):902–11. 10.2337/dc16-0382

[16]

Association Between Bariatric Surgery and Long-term Survival

David E. Arterburn, Maren K. Olsen, Valerie A. Smith et al.

JAMA 2015 10.1001/jama.2014.16968

[17]

Sjostrom L, Narbro K, Sjostrom CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357(8):741–52. 10.1056/nejmoa066254

[18]

Aminian A, Al-Kurd A, Wilson R, et al. Association of bariatric surgery with major adverse liver and cardiovascular outcomes in patients with biopsy-proven nonalcoholic steatohepatitis. JAMA. 2021;26(20):2031–42. 10.1001/jama.2021.19569

[19]

Association of Metabolic Surgery With Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity

Ali Aminian, Alexander Zajichek, David E. Arterburn et al.

JAMA 2019 10.1001/jama.2019.14231

[20]

Goldberg I, Yang J, Nie L, Bates AT, Docimo Jr S, Pryor AD, Cohn T, Spaniolas K. Safety of bariatric surgery in patients older than 65 years. Surg Obes Relat Dis. 2019;15(8):1380–7. 10.1016/j.soard.2019.05.016

[21]

Phillips BT, Shikora SA. The history of metabolic and bariatric surgery: development of standards for patient safety and efficacy. Metabolism. 2018;79:97–107. 10.1016/j.metabol.2017.12.010

[22]

Longitudinal Assessment of Bariatric Surgery (LABS) Consortium. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med. 2009;361:445–54. 10.1056/nejmoa0901836

[23]

Buchwald H, Estok R, Fahrbach K, Banel D, Sledge I. Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery. 2007;142(4):621–32. 10.1016/j.surg.2007.07.018

[24]

Arterburn DE, Telem DA, Kushner RF, Courcoulas AP. Benefits and risks of bariatric surgery in adults: a review. JAMA. 2020;324(9):879–87. 10.1001/jama.2020.12567

[25]

American Society of Metabolic and Bariatric Surgery (ASMBS) [Internet]. Newberry, FL: The Society [updated 2022 Jun; cited YYYY Mon D]. Estimate of Bariatric Surgery Numbers, 2011-2020; [about 2 screens]. Available from: https://asmbs.org/resources/estimate-of-bariatric-surgery-numbers.

[26]

International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO). 5th IFSO Global Registry Report [monograph on the Internet]. Naples, Italy: IFSO; 2019 [cited YYYY Mon D]. Available from: https://www.ifso.com/pdf/5th-ifso-global-registry-report-september-2019.pdf.

[27]

Rubino F, Nathan DM, Eckel RH, Schauer PR, Alberti KG, Zimmet PZ, del Prato S, Ji L, Sadikot SM, Herman WH, Amiel SA, Kaplan LM, Taroncher-Oldenburg G, Cummings DE, Delegates of the 2nd Diabetes Surgery Summit. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Surg Obes Relat Dis. 2016;12(1):1144–62. 10.1016/j.soard.2016.05.018

[28]

Aminian A, Chang J, Brethauer SA, Kim JJ, American Society for Metabolic and Bariatric Surgery Clinical Issues Committee. ASMBS updated position statement on bariatric surgery in class I obesity (BMI 30-35 kg/m2). Surg Obes Relat Dis. 2018;14(8):1071–87. 10.1016/j.soard.2018.05.025

[29]

Noun R, Slim R, Nasr M, Chakhtoura G, Gharios J, Antoun NA, Ayoub E. Results of laparoscopic sleeve gastrectomy in 541 consecutive patients with low baseline body mass index (30-35 kg/m2). Obes Surg. 2016;26(12):2824–8. 10.1007/s11695-016-2224-y

[30]

Varban OA, Bonham AJ, Finks JF, Telem DA, Obeid NR, Ghaferi AA. Is it worth it? Determining the health benefits of sleeve gastrectomy in patients with a body mass index <35 kg/m2. Surg Obes Relat Dis. 2020;16(2):248–53. 10.1016/j.soard.2019.10.027

[31]

Ikramuddin S, Komer J, Lee WJ, et al. Durability of addition of Roux-en-Y gastric bypass to lifestyle intervention and medical management in achieving primary treatment goals for uncontrolled type 2 diabetes in mild to moderate obesity: a randomized control trial. Diabetes Care. 2016;39(9):1510–8. 10.2337/dc15-2481

[32]

Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes

Philip R. Schauer, Deepak L. Bhatt, John P. Kirwan et al.

New England Journal of Medicine 2017 10.1056/nejmoa1600869

[33]

Courcoulas AP, Belle SH, Neiberg RH, Pierson SK, Eagleton JK, Kalarchian MA, DeLany JP, Lang W, Jakicic JM. Three-year out-comes of bariatric surgery vs lifestyle intervention for type 2 diabetes mellitus treatment: a randomized clinical trial. JAMA Surg. 2015;150(10):931–40. 10.1001/jamasurg.2015.1534

[34]

O’Brien PE, Brennan L, Laurie C, Brown W. Intensive medical weight loss or laparoscopic adjustable gastric banding in the treatment of mild to moderate obesity: long-term follow-up of a prospective randomised trial. Obes Surg. 2013;23(9):1345–53. 10.1007/s11695-013-0990-3

[35]

Parikh M, Chung M, Sheth S, McMacken M, Zahra T, Saunders JK, Ude-Welcome A, Dunn V, Ogedegbe G, Schmidt AM, Pachter HL. Randomized pilot trial of bariatric surgery versus intensive medical weight management on diabetes remission in type 2 diabetes patients who do NOT meet NIH criteria for surgery and the role of soluble RAGE as a novel biomarker of success. Ann Surg. 2014;260(4):617–22. 10.1097/sla.0000000000000919

[36]

Wentworth JM, Playfair J, Laurie C, Ritchie ME, Brown WA, Burton P, Shaw JE, O'Brien PE. Multidisciplinary diabetes care with and without bariatric surgery in overweight people: a randomised controlled trial. Lancet Diabetes Endocrinol. 2014;2(7):545–52. 10.1016/s2213-8587(14)70066-x

[37]

Busetto L, Dixon J, De Luca M, Shikora S, Pories W, Angrisani L. Bariatric surgery in class I obesity: a position statement from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO). Obes Surg. 2014;24(4):487–519. 10.1007/s11695-014-1214-1

[38]

Rubino F, Cohen RV, Mingrone G, le Roux CW, Mechanick JI, Arterburn DE, Vidal J, Alberti G, Amiel SA, Batterham RL, Bornstein S, Chamseddine G, del Prato S, Dixon JB, Eckel RH, Hopkins D, McGowan BM, Pan A, Patel A, et al. Bariatric and metabolic surgery during and after the COVID-19 pandemic: DSS recommendations for management of surgical candidates and postoperative patients and prioritisation of access to surgery. Lancet Diabetes Endocrinol. 2020;8(7):640–8. 10.1016/s2213-8587(20)30157-1

[39]

World Health Organization (WHO) [Internet]. Geneva, Switzerland: The Organization; 2022 [cited 2022 Apr 27]. Obesity and overweight [about 6 screens]. Available from: www.who.int/westernpacific/health-topics/obesity.

[40]

Misra A. Ethnic-specific criteria for classification of body mass index: a perspective for Asian Indians and American Diabetes Association position statement. Diabetes Technol Ther. 2015;17(9):667–71. 10.1089/dia.2015.0007

[41]

Hsu WC, Araneta MRG, Kanaya AM, Chiand JL, Fujimoto W. BMI cut points to identify at-risk Asian Americans for type 2 diabetes screening. Diabetes Care. 2015;38(1):150–8. 10.2337/dc14-2391

[42]

Gill RS, Karmali S, Sharma AM. The potential role of the Edmonton obesity staging system in determining indications for bariatric surgery. Obes Surg. 2011;21(12):1947–9. 10.1007/s11695-011-0533-8

[43]

Padwal RS, Pajewski NM, Allison DB, Sharma AM. Using the Edmonton obesity staging system to predict mortality in a population-representative cohort of people with overweight and obesity. CMAJ. 2011;183(14):E1059–66. 10.1503/cmaj.110387

[44]

Frattini F, Lavazza M, Rausei S, Rovera F, Boni L, Dionigi G. BMI: the weakness of a milestone in obesity management and treatment. Obes Surg. 2015;25(10):1940–1. 10.1007/s11695-015-1795-3

[45]

Al-Kurd A, Grinbaum R, Mordechay-Heyn T, et al. Outcomes of sleeve gastrectomy in septuagenarians. Obes Surg. 2018;28(12):3895–901. 10.1007/s11695-018-3418-2

[46]

Smith ME, Bacal D, Bonham AJ, Varban OA, Carlin AM, Ghaferi AA, Finks JF. Perioperative and 1-year outcomes of bariatric surgery in septuagenarians: implications for patient selection. Surg Obes Relat Dis. 2019;15(10):1805–11. 10.1016/j.soard.2019.08.002

[47]

Edwards MA, Mazzei M, Agarwal S, Rhodes L, Bruff A. Exploring perioperative outcomes in metabolic and bariatric surgery amongst the elderly: an analysis of the 2015–2017 MBSAQIP database. Surg Obes Relat Dis. 2021;17(6):1096–106. 10.1016/j.soard.2021.02.026

[48]

Watt J, Tricco AC, Talbot-Hamon C, Pham B’, Rios P, Grudniewicz A, Wong C, Sinclair D, Straus SE. Identifying older adults at risk of harm following elective surgery: a systematic review and meta-analysis. BMC Med. 2018;16(1):2. 10.1186/s12916-017-0986-2

[49]

Gondal AB, Hsu CH, Zeeshan M, Hamidi M, Joseph B, Ghaderi I. A frailty index and the impact of frailty on postoperative outcomes in older patients after bariatric surgery. Surg Obes Relat Dis. 2019;15(9):1582–8. 10.1016/j.soard.2019.06.028

[50]

Reilly JJ, Kelly J. Long-term impact of overweight and obesity in childhood and adolescence on morbidity and premature mortality in adulthood: systematic review. Int J Obes (Lond). 2011;35(7):891–8. 10.1038/ijo.2010.222

Showing 50 of 148 references

Cited By

532

Sleeve Gastrectomy Versus Banded Roux-en-Y Gastric Bypass for Obesity and Diabetes Mellitus: Psychology and Quality of Life Outcomes at 10 Years

Preekesh Suresh Patel, Megan Grinlinton · 2026

Obesity Surgery

Patient perspectives on access to bariatric surgical care in the Deep South: A qualitative study

Alfonsus Adrian H. Harsono, Gurudatta A. Naik · 2026

The American Journal of Surgery

Female sexual function, urinary incontinence, and sexual position use 5 years after bariatric surgery: a prospective cohort study

Magdalena Sternau, Mateusz Czajkowski · 2026

BMC Women's Health

Revised definition of obesity in Asian Indians living in India

Anoop Misra, Naval K. Vikram · 2025

Diabetes & Metabolic Syndrome:...

Primary Care Providers Perspectives of GLP-1 Receptor Agonists to Manage Recurrent Weight Gain after Metabolic Bariatric Surgery – a Qualitative Study

Liisa Tolvanen, Karin Mossberg · 2025

Obesity Surgery

Metabolic Syndrome: An Updated Review on Diagnosis and Treatment for Primary Care Clinicians

Carolyn Mae Peterseim, Katarzyna Jabbour · 2024

Journal of Primary Care & Commu...

Obesity

Adam H. Gilden, Victoria A. Catenacci · 2024

Annals of Internal Medicine

Protein Nutrition: Understanding Structure, Digestibility, and Bioavailability for Optimal Health

Nneka Ajomiwe, Mike Boland · 2024

Foods

Recomendaciones sobre el manejo de la obesidad grave en pacientes con enfermedad inflamatoria intestinal del Grupo Español de Trabajo en Enfermedad Inflamatoria Intestinal (GETECCU), Sociedad Española de Obesidad (SEEDO), Asociación Española de Cirugía (AEC) y Sociedad Española de Endoscopia Digestiva (SEED)

Eugeni Domènech, Andreea Ciudin · 2024

Gastroenterología y Hepatología

Metrics

532

Citations

148

References

Details

Published: Nov 07, 2022
Vol/Issue: 33(1)
Pages: 3-14
License: View

Authors

Bariatric and Metabolic Institute, Department of General Surgery, Cleveland Clinic, Cleveland, OH

Kasey P.S. Goodpaster

Cite This Article

Dan Eisenberg, Scott A. Shikora, Edo Aarts, et al. (2022). 2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Indications for Metabolic and Bariatric Surgery. Obesity Surgery, 33(1), 3-14. https://doi.org/10.1007/s11695-022-06332-1

2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Indications for Metabolic and Bariatric Surgery

You May Also Like